TAC102 is a novel component of the mitochondrial genome segregation machinery in trypanosomes by Trikin, Roman et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TAC102 is a novel component of the mitochondrial genome
segregation machinery in trypanosomes
Citation for published version:
Trikin, R, Doiron, N, Hoffmann, A, Haenni, B, Jakob, M, Schnaufer, A, Schimanski, B, Zuber, B &
Ochsenreiter, T 2016, 'TAC102 is a novel component of the mitochondrial genome segregation machinery
in trypanosomes', Plos pathogens, vol. 12, no. 5. https://doi.org/10.1371/journal.ppat.1005586
Digital Object Identifier (DOI):
10.1371/journal.ppat.1005586
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Plos pathogens
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 27. Jan. 2020
  1
TAC102 is a novel component of the mitochondrial genome segregation machinery in 1 
trypanosomes 2 
 3 
 4 
Roman Trikin1,2,¶, Nicholas Doiron1,¶, Anneliese Hoffmann1,2, Beat Haenni3, Martin Jakob1, 5 
Achim Schnaufer4, Bernd Schimanski1, Benoît Zuber3 and Torsten Ochsenreiter1,* 6 
 7 
 8 
1Institute of Cell Biology, University of Bern, Bern, Switzerland 9 
2Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, 10 
Switzerland 11 
3Institute of Anatomy, University of Bern, Bern, Switzerland 12 
4Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, 13 
Scotland, UK 14 
 15 
 16 
*Corresponding author 17 
E-mail: torsten.ochsenreiter@izb.unibe.ch (TO) 18 
 19 
 20 
¶These authors contributed equally to this work. 21 
 22 
 23 
 24 
 25 
 26 
  2
Abstract 1 
 2 
Trypanosomes show an intriguing organization of their mitochondrial DNA into a catenated 3 
network, the kinetoplast DNA (kDNA). While more than 30 proteins involved in kDNA 4 
replication have been described, only few components of kDNA segregation machinery are 5 
currently known. Electron microscopy studies identified a high-order structure, the tripartite 6 
attachment complex (TAC), linking the basal body of the flagellum via the mitochondrial 7 
membranes to the kDNA. Here we describe TAC102, a novel core component of the TAC, 8 
which is essential for proper kDNA segregation during cell division. Loss of TAC102 leads to 9 
mitochondrial genome missegregation but has no impact on proper organelle biogenesis and 10 
segregation. The protein is present throughout the cell cycle and is assembled into the newly 11 
developing TAC only after the pro-basal body has matured indicating a hierarchy in the 12 
assembly process. Furthermore, we provide evidence that the TAC is replicated de novo 13 
rather than using a semi-conservative mechanism. Lastly, we demonstrate that TAC102 lacks 14 
an N-terminal mitochondrial targeting sequence and requires sequences in the C-terminal part 15 
of the protein for its proper localization. 16 
 17 
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Author summary 1 
 2 
Proper segregation of the mitochondrial genome during cell division is a prerequisite of 3 
healthy eukaryotic cells. However, the mechanism underlying the segregation process is only 4 
poorly understood. We use the single celled parasite Trypanosoma brucei, which, unlike most 5 
model organisms, harbors a single large mitochondrion with a single mitochondrial genome, 6 
also called kinetoplast DNA (kDNA), to study this question. In trypanosomes, kDNA 7 
replication and segregation are tightly integrated into the cell cycle and thus can be studied 8 
alongside cell cycle markers. Furthermore, previous studies using electron microscopy have 9 
characterized the tripartite attachment complex (TAC) as a structural element of the 10 
mitochondrial genome segregation machinery. Here, we characterize TAC102, a novel 11 
trypanosome protein localized to the TAC. The protein is essential for proper kDNA 12 
segregation and cell growth. We analyze the presence of this protein using super resolution 13 
microscopy and show that TAC102 is a mitochondrial protein localized between the kDNA 14 
and the basal body of the cell´s flagellum. In addition, we characterize different parts of the 15 
protein and show that the C-terminus of TAC102 is important for its proper localization. The 16 
data and resources presented will allow a more detailed characterization of the dynamics and 17 
hierarchy of the TAC in the future and might open new avenues for drug discovery targeting 18 
this structure. 19 
 20 
 21 
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 26 
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Introduction 1 
 2 
Trypanosoma brucei cells harbor a single mitochondrial organelle with a single genome, the 3 
kinetoplast DNA (kDNA), which consists of two types of circular DNA molecules, the maxi- 4 
and minicircles [1,2]. Maxicircles (~23 kb) encode subunits of the respiratory chain, a 5 
ribosomal protein and ribosomal RNAs [1]. Most of the maxicircle-encoded transcripts 6 
require posttranscriptional modifications by RNA editing [3–6]. This process involves 7 
several, well characterized large enzyme complexes, the editosomes [7], and small guide 8 
RNAs (gRNAs), which are encoded by the minicircles (~1 kb). The kDNA is a network of 9 
physically linked mini- (~5000) and maxicircles (~25) that forms a highly condensed, disk-10 
like structure at the posterior end of the mitochondrion close to the basal body of the 11 
flagellum [1]. Replication of the kDNA occurs during the G1 phase of the cell cycle when the 12 
cells are characterized through the presence of one kDNA and one nucleus (1k1n) [8,9]. Prior 13 
to nuclear replication (S phase), the kDNA is segregated (2k1n) and, finally, after mitosis 14 
(G2/M) the cells contain two kDNAs and two nuclei (2k2n) [8,9]. More than 30 proteins have 15 
been characterized that are involved in the replication and compaction of the kDNA, however 16 
little is known about its segregation [1,2]. Also in yeast, the major model system for 17 
mitochondrial biology, knowledge about the mitochondrial genome segregation machinery is 18 
scarce [10–12]. There is evidence that the mitochondrial nucleoids are anchored via the inner 19 
and outer membranes of the organelle to the actin cytoskeleton and a number of proteins 20 
including Mmm1 and Mdm10/12/31/32/34 have been implicated in this process [10,13–16]. 21 
However most of these proteins are also involved in other processes related to mitochondrial 22 
morphology or mitochondrial ER contact sites [17–19], thus drawing final conclusions about 23 
their direct impact on mitochondrial genome segregation remains difficult. 24 
 25 
 26 
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The tripartite attachment complex (TAC) 1 
Elegant electron microscopy analysis revealed a structure that connects the basal body with 2 
the kDNA disk, the tripartite attachment complex (TAC) [20]. The TAC consists of (i) the 3 
exclusion zone filaments, a region between the basal body and the outer mitochondrial 4 
membrane devoid of ribosomes; (ii) the differentiated mitochondrial membranes, which are 5 
inert to detergent extraction; and (iii) the unilateral filaments that connect the inner 6 
mitochondrial membrane with the kDNA spanning a region that has been described as the 7 
kinetoflagellar zone (KFZ) [1,2]. Although the basal body does not directly belong to the 8 
TAC structure, it is a key organizer in the T. brucei cell and the posterior anchoring point of 9 
the TAC [1,2,21]. A few markers for the basal body and the TAC have been described. Basal 10 
body markers include YL1/2 that recognizes the aggregation of non-polymerized tyrosinated 11 
tubulin in the transitional fibers of the mature flagellum [22], and BBA4 that recognizes an 12 
unknown protein in the pro- and mature basal bodies [23]. Furthermore, two components of 13 
the exclusion zone filaments have been described. The monoclonal antibody MAB22 14 
recognizes a cytoskeletal component of the exclusion zone filaments ranging from the 15 
proximal end of the basal body to the outer mitochondrial membrane [24]. The unidentified 16 
structure recognized by MAB22 seems to be insensitive to extraction by high concentrations 17 
of non-ionic detergents, which is consistent with the earlier descriptions of the TAC. The 18 
other known component of the exclusion zone filaments is a ~197 kDa protein (p197), which 19 
was shown to localize in the same region as MAB22 by immunofluorescence microscopy 20 
[25]. Depletion of p197 leads to a kDNA segregation phenotype where most cells are devoid 21 
of kDNA and a small number of cells accumulate a huge amount of kDNA [25]. For the 22 
differentiated membranes, a recently described β barrel protein (TAC40) of the outer 23 
mitochondrial membrane (OM) has been demonstrated to be a TAC component [26]. 24 
Depletion of TAC40 leads to a phenotype similar to that described for p197. Additionally, 25 
electron microscopy studies demonstrated that the overall ultrastructure of the kDNA remains 26 
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intact but daughter networks are not separated in cells depleted of TAC40 [26]. Another 1 
protein of the differentiated membrane is p166, historically the first TAC component to be 2 
described, which localizes to the inner mitochondrial membrane and its depletion leads to a 3 
phenotype similar to that described above for p197 and TAC40 [27]. Additionally, it was 4 
shown that the kDNA loss phenotype upon p166 RNAi is indeed a consequence of 5 
asymmetrical segregation rather than improper replication of the mitochondrial genome [27]. 6 
Potential candidates for anchoring the kDNA to the intermediate filaments are the two 7 
universal minicircle sequence binding proteins (UMSBP1 and UMSBP2) [28,29]. A 8 
homologue of these proteins in Crithidia fasciculata has been shown to specifically bind to 9 
two conserved sequences in the minicircles [30]. While the main function of the UMSBPs 10 
seems to be the initiation of minicircle replication, they might have additional functions in 11 
kDNA segregation. Currently it is unclear, however, if the kDNA segregation phenotype that 12 
is seen upon the loss of both UMSBPs is a consequence of the loss of minicircle replication or 13 
the proteins are directly involved in segregating the kDNA in trypanosomes. Aside from the 14 
UMSBPs, there are currently no other candidates for intermediate filament proteins. 15 
Auxiliary factors of the TAC 16 
AEP-1 is a mitochondrially encoded protein produced from the alternatively edited 17 
cytochrome c oxidase III mRNA. Overexpression of a recoded nuclear version of the C-18 
terminally truncated AEP-1 (ΔC-AEP-1) led to a kDNA loss phenotype reminiscent of the 19 
phenotypes described above. Very likely this protein localizes to the inner mitochondrial 20 
membrane with a clear enrichment in the KFZ [31,32]. Recently, the α-ketoglutarate 21 
dehydrogenase E2 (α-KDE2) subunit, which is an essential Krebs cycle enzyme in the insect 22 
form trypanosomes, has been shown to be also important for proper kDNA segregation [33]. 23 
α-KDE2 seems to be localized throughout the mitochondrion and at the inner mitochondrial 24 
membrane and loss of this enzyme leads to a growth defect and a kDNA segregation 25 
phenotype. 26 
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In this study, we report a novel mitochondrial TAC protein (TAC102), which is likely part of 1 
the unilateral filaments. We show its localization throughout the cell cycle and characterize 2 
the phenotype which occurs during RNAi-induced loss of TAC102 and suggest a mechanism 3 
for the replication of the TAC structure. Additionally, we demonstrate that TAC102 has 4 
sequences in its C-terminus that are required for proper localization to the mitochondrial 5 
organelle and the TAC. 6 
 7 
 8 
 9 
 10 
 11 
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 14 
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Results 1 
 2 
TAC102 (Q57XN5; Tb927.7.2390) was discovered in an RNAi screen of proteins potentially 3 
involved in kDNA maintenance. To select candidates for the screen, we combined mRNA 4 
expression data from the T. brucei cell cycle (Fig S1D) as well as proteomics data from the 5 
life cycle differentiation [34] and the MitoCarta [35]. TAC102 (i) is a predicted mitochondrial 6 
protein, (ii) is most highly expressed at the mRNA level in the G1 phase of the cell cycle 7 
when the new TAC is assembled, and (iii) its expression is decreased at the protein level 8 
during the differentiation to the non-replicative short stumpy cells. TAC102 is a single-copy 9 
gene encoding a 102.86 kDa (951aa) basic protein with pI 9.42 (Fig S1). Orthologs of 10 
TAC102 can be found throughout the Kinetoplastea including T. brucei, T. cruzi, Leishmania 11 
spp., Crithidia sp. and Phytomonas sp. The C-terminal 120 amino acids of the protein are 12 
highly conserved among these species, but the middle part is variable and contributes to the 13 
varying pIs of the proteins. While the Leishmania spp., Crithidia sp. and Phytomonas sp. 14 
orthologs of TAC102 are acidic (pI around 4.5), the pI of the trypanosome orthologs that 15 
contain a lysine rich region (aa 653−756; 36% lysine) is above 9.4, suggesting different 16 
biochemical properties of these proteins. Previous studies detected posttranslational 17 
modifications of TAC102 – phosphorylation at positions 609 (T) and 614 (S) [36]. These 18 
residues are partially conserved among trypanosomes but not throughout the Kinetoplastea, 19 
however, little phosphoproteomics data is available for species other than T. brucei and 20 
Leishmania spp. (Fig S1).  21 
 22 
RNAi targeting TAC102 in bloodstream form (BSF) cells 23 
Using RNAi which targets the ORF of TAC102, we depleted the transcript in bloodstream 24 
form (BSF) parasites and detected slower cell growth after three days of RNAi induction (Fig 25 
1A). Seven days post RNAi induction the cells stopped growing entirely. The effectiveness of 26 
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RNAi was shown by probing for the TAC102 mRNA and protein on northern and western 1 
blots, respectively (Fig 1A). Analysis of the DNA content of BSF cells by DAPI staining and 2 
fluorescence microscopy showed that approximately 75% of the cells had lost the kDNA two 3 
days after induction of RNAi (Fig 1B-C), while a small number of cells contained very large 4 
or “tiny” kDNAs (Fig 1B, D). The median intensity of the remaining kDNAs in the 5 
population increased by more than two fold 48 hours post RNAi induction based on DAPI 6 
fluorescence intensity (Fig 1D). Overall the amount of kDNA in the population decreased to 7 
~45% of the wild type situation after two days of RNAi as measured by probing for the 8 
kDNA minicircles on Southern blots (Fig 1E). Also the number of cells properly segregating 9 
their kDNA (2k1n cells) dropped from ~15% in the uninduced population to less than 2% 10 
after two days of RNAi induction. Together with the appearance of very large kDNAs this 11 
suggests that loss of TAC102 has an impact on mitochondrial genome segregation rather than 12 
replication. In order to test if the loss of TAC102 also had influence on mitochondrial 13 
morphology, we stained the cells with antibody against the mitochondrial heat shock protein 14 
70 (mtHSP70). During the first two days of RNAi induction we did not detect any changes in 15 
mitochondrial morphology (Fig 1B), except in cells that accumulated very large kDNAs; here 16 
an increase in organelle volume at the site of the kDNA was observed. Also the segregation of 17 
the mitochondrial organelle during cell division even in the absence of kDNA seemed to be 18 
unaffected (Fig 1B). 19 
 20 
Essentially the same RNAi phenotype was observed in the insect form parasites (procyclic 21 
form, PCF; Fig S2). Here we also carefully characterized the cells (<1%) that showed unequal 22 
segregation of the kDNA (Fig S2I). In the majority of these cells the enlarged kDNA was 23 
associated with the old basal body and flagellum, and it was positioned in most cases between 24 
the two nuclei. Thus, in both life cycle forms of T. brucei loss of TAC102 leads to kDNA 25 
missegregation rather than kDNA replication defect, which in turn leads to the loss of the 26 
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mitochondrial genome in most cells. Based on our observations, we assume that in most cases 1 
the remaining kDNA is associated with the old basal body. 2 
 3 
Fig 1. RNAi against TAC102 in BSF cells causes missegregation and loss of kDNA. A – 4 
growth curve of cells uninduced (−Tet) and induced (+Tet) for TAC102 RNAi. Inset: 5 
northern blot probed for TAC102 and 18S rRNA (loading control). RNA was isolated from 6 
cells that were uninduced (−) or induced for two days (+). The western blot under the growth 7 
curve demonstrates downregulation of TAC102 protein upon induction of RNAi. Ai 8 
inductiwas used as a loading control. B – immunofluorescence images showing 9 
missegregation and loss of kDNA as well as the unchanged mitochondrial morphology upon 10 
induction of RNAi against TAC102. DNA is stained with DAPI (cyan). Mitochondria are 11 
visualized by staining for the mitochondrial heat-shock protein 70 (mtHSP70, red). C – 12 
percentage of cells with different k-n-combinations within the course of TAC102 RNAi. D – 13 
intensity of the kDNA signal measured by DAPI staining. E – the relative amount of 14 
minicircle DNA decreases within the course of TAC102 RNAi, according to Southern 15 
blotting. Tubulin was used for normalization and the amount of minicircle DNA in non-16 
induced cells (day 0) was taken as 100%. A representative Southern blot is shown on the right 17 
side of the graph. 18 
 19 
kDNA ultrastructure 20 
In order to investigate the ultrastructure of the enlarged kDNA networks in BSF cells we 21 
employed transmission electron microscopy. The kDNA is organized in a disk-shaped 22 
structure which is situated close to the inner mitochondrial membrane. When the kDNA disk 23 
is viewed from the “side”, the basal body can often be seen juxtaposed on the other side of the 24 
mitochondrial membranes (Fig 2A). Just prior to kDNA segregation, the kDNA assumes a 25 
kinked conformation (Fig 2B), which can be explained through the connection of the kDNA 26 
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to the basal bodies and the movement of the new basal body around the old one. In BSF cells 1 
with enlarged kDNA networks two days after the induction of RNAi against TAC102 the 2 
kDNA generally maintains the striated ultrastructure of the disk (Fig 2C-D), however it does 3 
not assume a clear kinked structure (Fig 2C) and often the kDNA seems folded upon itself 4 
with additional smaller kDNA disks (Fig 2D). The median diameter of the sum of the striated 5 
kDNA disks from the enlarged networks was around 680 nm compared to 440 nm in the 6 
parental cell line (Fig 2G). In some cells, instead of a properly structured kDNA, we detected 7 
small patches of electron dense material (edm) lacking the typical striated appearance with a 8 
median diameter of 320 nm (Fig 2E). In the case of complete loss of the kDNA, the 9 
mitochondrial membranes remain in close proximity to the basal bodies and appear intact (Fig 10 
2F). It also seems that the exclusion zone is unaffected since few or no ribosomes are present 11 
in this area (Fig 2F). 12 
 13 
Fig 2. Ultrastructure of kDNA upon RNAi against TAC102 in BSF cells revealed by 14 
transmission electron microscopy. bb, basal body; mm, mitochondrial membrane; edm, 15 
electron dense material; −Tet, non-induced cells; +Tet, cells with TAC102 RNAi induced for 16 
two days. A,B – kDNA in a non-induced cells. C,D – examples of enlarged kDNA in cells 17 
induced for TAC102 RNAi for two days. The arrows point at additional patches of kDNA. E 18 
– example of a cell induced for TAC102 RNAi for two days that has lost the kDNA, instead 19 
only a small patch of electron dense material (edm) can be seen surrounded by the 20 
mitochondrial membrane (mm) and localized in the proximity to the basal body (bb). F – an 21 
example of a cell induced for TAC102 RNAi for two days that has lost the kDNA and does 22 
not have any detectable electron dense material (edm); however, the mitochondrial membrane 23 
(mm) and the basal body (bb) are seen well. G – quantification of the kDNA diameter, 24 
measured as shown in A (white bar), in non-induced and induced cells. 25 
 26 
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TAC102 is a component of the mitochondrial segregation machinery 1 
Loss of kDNA is a frequent phenotype observed in trypanosomes when mitochondrial 2 
functions are affected. To test if loss of TAC102 has a direct or indirect effect on kDNA 3 
segregation, we made use of a recently described T. brucei BSF cell line that contains a single 4 
point mutation in the γ-subunit of the ATP-synthase (γL262P) and is able to shed its kDNA 5 
without any detectable growth defect [37]. RNAi targeting the ORF of TAC102 mRNA in 6 
this cell line led to the same phenotype as described above, i.e. loss of kDNA in the majority 7 
of cells and large/tiny kDNA networks in few cells; however, in this case the cells lacking 8 
kDNA continued to grow at wild type rates eventually leading to an akinetoplastic population 9 
without any defects in basal body or flagellar biogenesis. These experiments demonstrate that 10 
TAC102 is only essential in cells that require kDNA for proper growth (Fig 3A-C). 11 
 12 
Fig 3. RNAi against TAC102 in re  defeBSF cells affects kDNA segregation but not cell 13 
growth. A – growth curve of cells uninduced (–Tet) and induced (+Tet) for TAC102 RNAi. 14 
Inset: northern blot probed for TAC102 and 18S rRNA (loading control). RNA was isolated 15 
from cells that were uninduced (−) or induced for two days (+). B – epifluorescence images 16 
(DAPI staining) of cells upon induction of RNAi against TAC102 for two days. C – 17 
percentage of cells with different k-n-combinations within the course of TAC102 RNAi. 18 
 19 
Localization of TAC102 20 
In order to localize TAC102 in cells, the protein was tagged in situ at the N-terminus using a 21 
dual affinity tag PTP (ProtC-TEV-ProtA; [38]). Super-resolution confocal microscopy using a 22 
STimulated Emission Depletion (STED) instrument showed co-localization of the N-23 
terminally tagged TAC102 with MitoTracker in BSF cells (Fig 4A). Immunofluorescence 24 
microscopy detected the protein in the posterior part of the mitochondrial organelle between 25 
the basal body of the flagellum and the kDNA disk, in both BSF (Fig 4B) and PCF (Fig 4D) 26 
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cells. The localization pattern of the tagged TAC102 was also confirmed in BSF and PCF 1 
cells by immunostaining with polyclonal and monoclonal antibodies against TAC102 (Fig 2 
S2M-N). Furthermore, biochemical fractionation using digitonin and differential 3 
centrifugation steps supported the mitochondrial localization of TAC102 (Fig 4C). We 4 
attempted to investigate the localization in more detail using different concentrations of 5 
digitonin to extract cells (Fig 4E). TAC102 is observed in the soluble fraction at 0.1% 6 
detergent, resembling the behavior of lipid dehydrogenase (LipDH), a mitochondrial matrix 7 
protein. However, the archaic translocase of the outer mitochondrial membrane (ATOM) and 8 
the inner mitochondrial membrane protein cytochrome oxidase subunit 4 (COXIV), known to 9 
strongly associate with membranes, are solubilized only at 0.3% digitonin. From this we 10 
conclude that TAC102 is likely to localize in the mitochondrial matrix (Fig 4E). In order to 11 
test if TAC102 is indeed part of the TAC structure, we analyzed flagella isolated from BSF 12 
cells for the presence of the basal body, TAC102 and the kDNA using immunofluorescence 13 
microscopy (Fig 5). Under these conditions, >90% of the flagella showed a signal for the 14 
basal body and about 50% had kDNA attached to their posterior end as demonstrated by 15 
DAPI staining. Of the kDNA-positive flagella, >90% had a signal for TAC102 in close 16 
proximity to the basal body and the kDNA, indicating that TAC102, similarly to the 17 
previously described TAC40 and p166, is a component of the TAC. We also analyzed flagella 18 
isolated from PCF cells using immunofluorescence microscopy and western blotting (Fig S3). 19 
Similarly to BSF cells, we observed that most flagella were positive for the presence of the 20 
TAC102 signal and the kDNA. In order to reslove the flagellar extract by SDS-PAGE and 21 
probe for TAC102 by western blotting, we had to treat the extracted flagella with DNAse I. 22 
TAC102 was found in both the flagellar and the soluble fractions, indicating that some part of 23 
the protein is solubilized by Triton X-100 used for flagella isolation, whereas a significant 24 
portion is retained at the flagella. 25 
 26 
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Fig 4. Localization of TAC102 in BSF and PCF T. brucei. A – STED microscopy image 1 
showing localization of N-PTP-TAC102 within the mitochondrion of a BSF cell. The 2 
mitochondria are stained with MitoTracker (gray, first image). The N-PTP-TAC102 is 3 
visualized by α-ProteinA antibody (gray, second image). In the Overlay/Zoom, the 4 
mitochondrion is shown in red and TAC102 – in yellow. Scale bar 2 e). B – 5 
immunofluorescence microscopy images showing the localization of N-PTP-TAC102 6 
between the kDNA and the basal body of the flagellum in a BSF cell. DNA is stained with 7 
DAPI (cyan). The N-PTP-TAC102 is visualized by -PProteinA antibody (red) and the basal 8 
body (YL1/2) is shown in green. The outline of the cell is shown with a white dashed line. 9 
Scale bar 2 µm, inset is a 200% zoom. C – western blot of a digitonin fractionation of BSF 10 
cells expressing N-PTP-TAC102. ATOM, a mitochondrial protein, and ALBA3, a cytosolic 11 
protein, are used as controls of the fractionation. D – immunofluorescence microscopy images 12 
showing the localization of TAC102 between the kDNA and the basal body of the flagellum 13 
in a PCF cell. DNA is stained with DAPI (cyan). TAC102 is visualized by  by ). TAC102 is 14 
visualized by by with DAPI (cyan). TAC102 iα-YL1/2 antibody (green). E – western blots of 15 
digitonin fractionations from PCF cells. Fractionations were performed with different 16 
concentrations of the detergent. total, total cell lysate; sup, supernatant. LipDH, lipid 17 
dehydrogenase, a mitochondrial matrix protein; ATOM, archaic translocase of the outer 18 
mitochondrial membrane; COXIV, cytochrome oxidase subunit 4, an inner mitochondrial 19 
membrane protein. 20 
 21 
Fig 5. TAC102 remains associated with the flagellum after flagellar extraction of BSF 22 
cells. Immunofluorescence analysis was performed with flagella isolated from BSF cells that 23 
express N-PTP-TAC102. The flagella are stained with PFR antibody (yellow). The structure 24 
at the end of the flagellum (in a white square box) is enlarged to show the kDNA (stained 25 
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with DAPI) in cyan, the basal body (visualized with α-BBA4 antibody) – in green and N-1 
PTP-TAC102 (detected by α-ProteinA antibody) – in red. Scale bar 1 -02 2 
 3 
TAC102 during the cell cycle 4 
A more detailed analysis of the localization of TAC102 using immunofluorescence 5 
microscopy shows that the protein is present throughout the cell cycle in whole cells (Fig 6). 6 
In the G1 phase, prior to kDNA replication, the TAC102 signal occupies a region between the 7 
basal body and the kDNA that is smaller than the kDNA structure as seen by DAPI staining 8 
(Fig 6A). Furthermore, based on staining of TAC102 and the mature basal body (YL1/2 9 
antibody), the new TAC102 signal only appears after the new basal body matures (Fig 6B-C). 10 
During the nuclear S phase, the new basal body moves to its posterior position and TAC102 is 11 
present at both the old and the new basal body (Fig 6E-F). In G2/M, after kDNA segregation, 12 
TAC102 remains between the kDNA and the basal body as described for the situation in G1 13 
(Fig 6G). 14 
 15 
TAC replication 16 
In order to test if the TAC is replicated de novo or by a semi-conservative mechanism, we 17 
induced RNAi against TAC102 in BSF cells for a short period (18 hours) and stained the cells 18 
with antibodies against TAC102 and the basal body (YL1/2) (Fig S4). As expected, in non-19 
induced cells each basal body is associated with a TAC102 signal and a kDNA. However, 20 
when TAC102 was depleted by RNAi for 18 hours, we observed cells that had two basal 21 
bodies, but just one TAC102 signal and one kDNA associated with it. The percentage of such 22 
cells in the population is 9.4%. Of such cells, more than 90% have the TAC102 signal/kDNA 23 
at the more anterior, old basal body. These experiments suggest that TAC102 is assembled de 24 
novo into the TAC. 25 
 26 
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Fig 6. Localization of TAC102 in BSF T. brucei during different stages of kDNA 1 
replication. Immunofluorescence images show the localization of N-PTP-TAC102 (detected 2 
by α-ProteinA antibody, red), the basal body (YL1/2, green) and the kDNA (stained with 3 
DAPI, cyan). A schematic model corresponding to each situation is shown on the right side of 4 
the images. Panels A to G represent different stages during kDNA replication. Scale bar 1 ffe 5 
 6 
Characterization of TAC102 domains 7 
Since TAC102 does not contain a detectable mitochondrial targeting signal at the N-terminus 8 
we aimed to characterize the region of the protein necessary for its proper localization to the 9 
TAC. For this we overexpressed inducible ectopic copies of N-terminally myc-tagged 10 
TAC102 in PCF parasites that were (i) truncated at the N-terminus (deletion of the first 200 11 
aa, myc∆N-TAC102) or (ii) the C-terminus (deletion of aa 650−951, myc∆C-TAC102), as 12 
well as (iii) the full-length TAC102 (myc-TAC102) and followed their localization in the cell 13 
by fluorescence microscopy and biochemical digitonin fractionation. The truncations cover 14 
most of the conserved regions of TAC102 in the N- and C-terminus. Myc-TAC102 localizes 15 
to the position of the endogenous protein as determined by immunofluorescence microscopy 16 
and western blotting of digitonin fractionations (Fig 7, S5). Furthermore, overexpression of 17 
the N-terminally tagged TAC102 does not lead to any detectable growth or cell cycle 18 
phenotype (Fig 7, S5, S6A). The N-terminally truncated TAC102 (myc∆N-TAC102) 19 
localizes to the TAC, however after five days of overexpression 25% of the cells show 20 
additional foci of myc∆N-TAC102 that are in the mitochondrial organelle as confirmed by 21 
biochemical fractionation; some of the TAC102 foci co-localize with small ancillary 22 
kinetoplasts (Fig 7, S5). Most of the cells with ancillary kDNAs, >80%, have one “extra” 23 
kDNA per cell (Fig S6B). After five days of induction we also could detect a reduction in the 24 
number of cells in G1 (1k1n) as well as an increase in cells without kDNA (10%, Fig S6A). 25 
Furthermore, myc∆N-TAC102 cells displayed a very weak growth defect that starts six days 26 
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post induction of overexpression of the protein. Thus the N-terminus of TAC102 is not 1 
required for import into the mitochondrion and targeting to the TAC but prolonged 2 
overexpression of the N-terminally truncated version leads to additional TAC102 foci, some 3 
of which associate with ancillary kinetoplasts. The C-terminally truncated TAC102 (myc∆C-4 
TAC102), on the other hand, does not localize to the mitochondrion or the TAC but 5 
accumulates in what is likely the cytoplasm (Fig 7, S5), indicating that the C-terminus may be 6 
important for proper localization to the organelle. This was also supported by the biochemical 7 
digitonin fractionations that showed the majority of TAC102 in the supernatant fraction (Fig 8 
7). 9 
 10 
Since the myc∆N-TAC102 localizes to the TAC, we wanted to test if the mutant protein can 11 
complement the depletion of the endogenous TAC102. For this we used RNAi targeting the 3' 12 
UTR of the endogenous TAC102 mRNA (Fig S2D-I). In this experiment the ectopically 13 
expressed myc∆N-TAC102 or myc-TAC102 mRNAs contained the aldolase 3' UTR and thus 14 
were not affected by RNAi targeting the native TAC102 3’ UTR (Fig 8). Myc-TAC102 is 15 
able to partially rescue the TAC102 RNAi phenotype. The growth defect is delayed by two 16 
days, when compared to the cells without complementation (Fig 8 and S2D). Most 17 
importantly, even after five days of RNAi induction and simultaneous overexpression the 18 
majority of cells (>98%) still contain kDNA, albeit in many cases additionally to the proper 19 
posterior location also at non-conventional positions within the mitochondrion (Fig 8 and S6). 20 
These ancillary kinetoplasts co-localize with additional TAC102 punctae (Fig 8). In this cell 21 
line, more than 60% of the cells with ancillary kinetoplasts had just one “extra” kDNA 22 
structure per cell after five days of induction (Fig S6B). The N-terminally truncated TAC102 23 
(myc∆N-TAC102), on the other hand, is unable to rescue the kDNA loss phenotype induced 24 
by RNAi against the endogenous TAC102. On day five post induction >60% of cells have 25 
lost their kDNA, while 14% show ancillary kDNAs (Fig 8 and S6). In the cells that have 26 
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“extra” kDNA, we observe one, two or three ancillary kinetoplasts per cell appearing in the 1 
population with similar frequencies, and we also sometimes detect cells with even more 2 
“extra” kDNA structures (Fig S6B). In summary, we have shown that the N-terminus of 3 
TAC102 is not required for its proper localization to the mitochondrion and the TAC, 4 
however it is required for proper function since the N-terminal deletion mutant of TAC102 is 5 
unable to rescue the loss of the endogenous protein. Furthermore, even though the full length 6 
N-terminally tagged TAC102 partially rescues the TAC102 RNAi phenotype, it leads to extra 7 
TAC102 and kDNA foci, indicating that the proper function of the protein is compromised by 8 
the myc-tag. 9 
 10 
Fig 7. Analysis of truncated versions of TAC102 upon their overexpression. The full-11 
length (myc:full), N-terminally (myc:Δyc or C-terminally (myc:Δyc truncated TAC102 was 12 
expressed with a triple myc-tag at the N-terminus in PCF cells. Immunofluorescence images 13 
show the localization of the tagged proteins. DNA is stained with DAPI (cyan) and myc-14 
tagged proteins (visualized by bymyc antibody) are shown in magenta. The star (myc:yc, day 15 
5) indicates an ancillary kinetoplast and the arrows indicate accumulation of the protein. For 16 
each of the three cell lines, western blots of digitonin fractionations are shown. ATOM (a 17 
mitochondrial protein) and EF1) and EF1 protein) and EF1t used as fractionation controls. T, 18 
total cell lysate; S, supernatant; P, pellet. Fractionations were performed on day 1 post 19 
induction. The growth curves show cell growth upon expression of the tagged proteins. The 20 
western blots on the right side of the growth curves show expression levels of the tagged 21 
versions of TAC102 in comparison to those of the endogenous protein. EF1α is used as a 22 
loading control. 23 
 24 
Fig 8. The myc:full version of TAC102 is able to partially compensate for the loss of the 25 
endogenous TAC102 but the myc:Δy is not. The full-length (myc:full) or the N-terminally 26 
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truncated (myc:yc: version of TAC102 was expressed with a triple myc-tag at the N-terminus 1 
in PCF cells that contain a construct for inducible RNAi against the 3´-UTR of the 2 
endogenous TAC102. Immunofluorescence images show the localization of the tagged 3 
proteins. DNA is stained with DAPI (cyan) and myc-tagged proteins (visualized by α-myc 4 
antibody) are shown in magenta. Arrows show additional foci of TAC102 accumulation. Stars 5 
show ancillary kDNAs. For each of the two cell lines, growth curves of the cells upon 6 
expression of the tagged proteins/knockdown of the endogenous TAC102 are shown on the 7 
right side of the immunofluorescence images. Under the growth curves are western blots that 8 
show expression levels of the tagged versions of TAC102 in comparison to those of the 9 
endogenous protein. EF1α is used as a loading control. Underneath are western blots of 10 
digitonin fractionations. ATOM (a mitochondrial protein) and EF1hown on the right side of 11 
the immunofluorescence images. Under the growth curves are western blots that show 12 
expression levels of the tagged versi5 of induction. 13 
 14 
The C-terminus of TAC102 is important for its localization to the mitochondrion 15 
Since the C-terminal deletion mutant of TAC102 (myc∆C-TAC102) mislocalized to the 16 
cytoplasm, we hypothesized that the targeting signal for mitochondrial import of TAC102 is 17 
in the C-terminal 301 aa of the protein. This was supported by bioinformatics analysis that 18 
predicted the last 18 and 36 aa of TAC102 to form amphipathic helices (Fig S7), a hallmark 19 
of N-terminal targeting sequences and one C-terminally targeted protein in yeast [39–41]. 20 
Furthermore, the last 116 aa of TAC102 are highly conserved among Kinetoplastea 21 
supporting the hypothesis that this region might be important for the function of the protein. 22 
Thus in an attempt to investigate the potential role of the C-terminal part of TAC102 in 23 
mitochondrial import, we created four PCF cell lines expressing different parts of the C-24 
terminus of TAC102 that were C-terminally fused to GFP. As a positive control, we used 25 
GFP with a known N-terminal targeting sequence. We induced and followed the expression of 26 
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the chimeric proteins by fluorescence microscopy and western blotting after digitonin 1 
fractionation (Fig S8). While the GFP containing the N-terminal mitochondrial targeting 2 
signal was imported into the mitochondrion, we found mostly cytosolic localization when we 3 
added 18, 36, or 116 of the TAC102 C-terminus to the GFP and induced expression of the 4 
protein overnight. However, when we added the last 301 aa of the C-terminus of TAC102 to 5 
GFP, we noticed (i) co-localization with the mitochondrial marker ATOM and (ii) that the 6 
mitochondrial network morphology was compromised. In order to further investigate this 7 
observation, we expressed this GFP construct for a shorter period of time (Fig 9). After 1 and 8 
2 hours of induction, individual cells started to express the GFP chimera that co-localized 9 
with the mitochondrial marker but no change in mitochondrial morphology could be detected. 10 
However, as early as 3 and 4 hours post expression of the GFP chimera the organelle 11 
morphology started to change. We were unable to corroborate immunofluorescence 12 
microscopy data by digitonin fractionations, as only few cells expressed GFP-301aa at these 13 
early time points (Fig S9) and the overall level of expression was below detection by western 14 
blotting. Thus overexpression of the 301 C-terminal amino acids from TAC102 fused with 15 
GFP eventually leads to changes in the morphology of the mitochondrial organelle, while the 16 
protein localizes, at least partially, to the organelle. From these experiments we conclude that 17 
the C-terminus is important for localization to the mitochondrial organelle but is unable to 18 
target the protein to the TAC. 19 
 20 
Fig 9. Ectopic expression of GFP-301aa fusion protein in PCF cells at early time points 21 
of induction. GFP-301aa is a chimeric protein where the last 301 aa of TAC102 are fused to 22 
the C-terminus of GFP. Expression of GFP-301aa was induced for 1, 2, 3 or 4 hours. 23 
Immunofluorescence images show the localization of GFP-301aa (visualized by α-GFP 24 
antibody, green). The mitochondrial heat-shock protein 70 (mtHSP70) is used as a 25 
mitochondrial marker (red). DNA is stained with DAPI (cyan). 26 
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 1 
 2 
Discussion 3 
 4 
RNAi against TAC102 in BSF and PCF cells (Fig 1, S2) leads to missegregation of the kDNA 5 
and eventually to kDNA loss in a large part of the population. While DAPI staining reveals a 6 
dramatic loss of kDNA already two days post induction of RNAi in BSF cells (>75% 0k1n 7 
cells), the detection of minicircles by Southern blotting shows a much less dramatic loss at 8 
this time. The apparent discrepancy can be explained by (i) the increase of kDNA in some 9 
cells that retain the kinetoplast (Fig 1D) and (ii) the appearance of small kDNA structures 10 
(Fig 1B, 2), which sometimes may be too small to be identified on microscopic images of 11 
DAPI stained cells but still can be detected by Southern blotting. 12 
 13 
The effect of RNAi against TAC102 on kDNA segregation is further illustrated by our TEM 14 
experiments (Fig 2). Upon loss of TAC102, we observe enlarged kDNAs, retaining the 15 
striated structure and the overall kinetoplast morphology seen in wild type cells. Sometimes 16 
additional small but well structured kDNAs were attached to the non-segregated networks, 17 
similarly to what has been described for p166 and TAC40 [26,27]. Interestingly, we also 18 
observed small patches of electron dense material (edm) in some cells. We assume that these 19 
could be the “small” kinetoplasts, which we also detect in epifluorescence microscopy upon 20 
the knockdown of TAC102 (Fig 1B). The edm does not have the typical appearance and the 21 
structure of kDNA and is never seen together with regular, well-structured kDNAs in the 22 
same cell. We speculate that, when the kDNA size is reduced past a certain threshold after 23 
improper segregation, the network loses some structural proteins and is not able to condense 24 
properly. 25 
 26 
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We have shown that TAC102, similarly to p166 and TAC40, is associated with isolated 1 
flagella from BSF and PCF cells, indicating that the protein is tightly bound to the TAC (Fig 2 
5, S3). However, in biochemical fractionations with increasing concentrations of digitonin the 3 
protein is readily soluble, similarly to a typical matrix protein (Fig 4E). So how can TAC102 4 
remain at flagella upon treatment with a strong detergent such as Triton X-100, used for 5 
flagellar isolation, and be relatively soluble upon digitonin fractionation? We speculate that 6 
TAC102 forms a multimeric structure in the TAC which is partially soluble, probably due to a 7 
different degree of association with other components. Alternatively, the difference in the 8 
solubilization by digitonin and Triton X-100 might also be explained by the difference in the 9 
chemical nature of the detergents. 10 
 11 
Based on the RNAi studies, TAC102 is a component of the mitochondrial genome 12 
segregation machinery and loss of TAC102 does not alter mitochondrial morphology (Fig 1B) 13 
or the ability to properly segregate the organelle during cell division, similarly to what we 14 
recently described for TAC40 [26], an outer mitochondrial membrane component of the TAC. 15 
Thus, mitochondrial genome segregation and organelle segregation are two independent 16 
processes and failure to properly segregate the mitochondrial genome does not directly impact 17 
cell division. The apparently exclusive function of TAC102 in kDNA segregation is 18 
supported by our experiments in the γ-L262P mutant trypanosomes (Fig 3), a cell line that is 19 
able to compensate for mitochondrial genome loss through a mutation in the γ-subunit of the 20 
ATP synthase [37]. When depleted of TAC102, the γ-L262P cell line shows the kDNA loss 21 
phenotype as described above, however, without any growth defect. This demonstrates that in 22 
the γ-L262P TAC102 RNAi cells no essential function is compromised. The exclusive 23 
function of TAC102 and the recently described protein TAC40 [26] in kDNA segregation is 24 
suprising since in yeast, for example, all known segregation factors are also involved in other 25 
functions, including maintenance of ER-mitochondrial contact sites and organelle 26 
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morphology [17–19]. This makes trypanosomes a very attractive model system to study 1 
mitochondrial DNA segregation, as components of the kDNA segregation machinery are 2 
unlikely to be implicated in other processes. 3 
Interestingly, the phenotypes that are observed upon TAC102, p166, TAC40 or p197 4 
depletion are very similar in kinetics and extent of kDNA loss [25–27]. Additionally, for 5 
TAC102 and TAC40 it has now been demonstrated that their function is exclusively 6 
associated with mitochondrial genome maintenance. Based on the similarities in loss of 7 
function phenotypes we speculate that the same is true for p197 and p166. Thus these four 8 
components of the TAC behave differently from the previously described TAC-associated 9 
components ACP, AEP-1 or α AEP- that are also required for proper kDNA maintenance but 10 
either have additional functions, like α-KDE2 [33], or are more indirectly involved in the 11 
segregation, like ACP that is crucial for proper lipid biogenesis [42]. AEP-1 is a special case 12 
since it is the only mitochondrially encoded component reported so far and, while it showed 13 
enriched localization at the TAC, it was also detected throughout the mitochondrial organelle, 14 
hinting at other potential functions of this protein [31,32]. Thus we consider TAC102, 15 
TAC40, p166 and p197 to be the “core” components of the TAC. 16 
 17 
The TAC102 RNAi experiments show that enlarged kDNAs mostly associate with the old 18 
basal body and cells that retain two kinetoplasts (2k2n cells), although very rare, mostly show 19 
unequal segregation of the mitochondrial genomes (Fig S2I), a phenomenon that was 20 
previously also observed in cells depleted of p166 [27]. The specific loss of the kDNA–new 21 
basal body connection argues that the old basal body−kDNA connection is, at least initially, 22 
not affected by RNAi targeting TAC102 or p166. Thus the TAC that is associated with the 23 
new basal body is likely assembled as a de novo structure rather than replicated in a semi-24 
conservative mode, in which case we would have expected a random loss of the basal 25 
body−kDNA connection. This is further corroborated by our experiments demonstrating that 26 
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the loss of TAC102 upon RNAi preferentially occurs at the new basal body−kDNA 1 
connection, leaving the old basal body−kDNA connection intact (Fig S4). 2 
 3 
A peculiar observation was the small ancillary kDNAs that appeared upon expression of 4 
several tagged TAC102 constructs (myc:yc-TAC102; myc:yc-TAC102 and myc-tagged full 5 
length TAC102 both in the absence of the endogenous protein). These results suggest that the 6 
N-terminus of TAC102 is important for the connection to upstream components of the TAC 7 
(closer to the basal body) and its deletion or obstruction by a tag leads to a partial loss of 8 
function of the protein, namely the proper localization at the TAC. Furthermore, the results 9 
indicate that the C-terminal part of the protein in the absence of the N-terminus is sufficient to 10 
either directly connect to kDNA or initiate the assembly of the downstream components that 11 
connect to the kDNA and thus initiate the appearance of the ancillary kinetoplasts that have 12 
lost the connection to the upstream components of the TAC and, consequently, the basal 13 
body. Ancillary kinetoplasts naturally occur in several Kinetoplastea species but the 14 
frequency of their appearance in T. brucei is very low and under normal culture conditions 15 
these “extra” kDNAs are rarely detected [43]. However, there are examples where depletion 16 
or overexpression of mitochondrial proteins leads to additional kDNA structures in the 17 
mitochondrion. In Tim17 RNAi cells up to 10% of the population accumulate extra kDNA 18 
[44], but since Tim17 is a protein import component, this effect is likely indirect and occurs 19 
due to the loss of kDNA segregation/replication factors, e.g. POLIB and POLIC, which, if 20 
depleted by RNAi, also lead to the appearance of ancillary kDNA structures [45]. The 21 
depletion of the mitochondrial acyl carrier protein (ACP), a key component of the fatty acid 22 
synthesis pathway, was also shown to produce “extra” kDNA structures, which could be due 23 
to the loss of the “special” membrane structures in the TAC [42]. On the other hand, 24 
overexpression of PUF9 target 1 (PNT1), a mitochondrial protein of unknown function that 25 
localizes to the kDNA, is also able to induce ancillary kDNA appearance [46]. 26 
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 1 
Based on biochemical fractionations and fluorescence microscopy, including super-resolution 2 
microscopy (STED), as well as previously published proteomics data [47], TAC102 is a 3 
mitochondrial protein that localizes to the posterior region of the mitochondrial organelle 4 
between the basal body and the kDNA (Fig 4, 5, 6, S3 and S4). Interestingly, TAC102 does 5 
not contain a classical N-terminal mitochondrial targeting signal but, based on the Δb-mutant 6 
analysis, rather a region within the C-terminus seems to be involved in proper localization to 7 
the mitochondrial organelle in vivo (Fig 7, 8, 9, S5 and S8). This was further supported by the 8 
bioinformatics analysis that predicted the presence of amphipathic helices at the C-terminus 9 
of TAC102 (Fig S7), similarly to the yeast helicase Hmi1p that was shown to be imported 10 
into mitochondria via a C-terminal targeting sequence [39]. To test the hypothesis, we 11 
designed a series of cell lines expressing GFP C-terminally fused with C-terminal sequences 12 
of TAC102 of different length. We reasoned that, if there is a targeting signal within the C-13 
terminus, we should be able to target the GFP chimeras to the mitochondrion. However, the 14 
18 and 36 aa of the C-terminus of TAC102 are not sufficient to target chimeric GFP proteins 15 
to the mitochondrial organelle. Their failure to properly localize could be explained by 16 
misfolding of the GFP chimeras. Nonetheless, they are detectable in the cytoplasm without 17 
any apparent degradation (Fig S8), which we would not expect for misfolded proteins. 18 
Furthermore, amphipathic helices, in general, are readily transferable to the N-terminus of 19 
GFP without any deleterious effect (for example, see positive control, Ntarget-GFP, in Fig 20 
S8). Thus the more likely explanation is that the predicted amphipathic helix is not sufficient 21 
for proper import in vivo and additional internal regions of TAC102 are required for this 22 
function. This is supported by the fact that the C-terminal 301 amino acids C-terminally fused 23 
to GFP are able to target the chimera to the mitochondrion (Fig 9, S8), although the 24 
expression of GFP-301aa leads to strong vesiculation of the mitochondrial network when 25 
expressed for more than two hours (Fig 9, S8). We hypothesize that GFP-301aa interacts with 26 
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the mitochondrial outer membrane and either blocks mitochondrial protein import or 1 
alternatively impacts one or several of the mitochondrial morphology factors, which are not 2 
well characterized in trypanosomes. The only mitochondrial protein in trypanosomes that has 3 
been described to harbor an internal targeting sequence is the Trypanosome Alternative 4 
Oxidase (TAO) [48]. TAO is a mitochondrial inner membrane protein equipped with an N-5 
terminal as well as an internal targeting sequence both of which are sufficient to target the 6 
protein. In other systems, e.g. yeast, most mitochondrial inner membrane proteins do not 7 
possess a classical N-terminal targeting sequence, and several, like the cytochrome c heme 8 
lyase or BCS1, have been described to harbor internal targeting signals [49–51]. This raises 9 
the question if TAC102 is localized in the inner mitochondrial membrane or even the 10 
intermembrane space? Based on bioinformatics analysis there is no predicted transmembrane 11 
domain in TAC102 and biochemical digitonin fractionations performed with different 12 
concentrations of the detergent demonstrate that the protein behaves like LipDH, a 13 
mitochondrial matrix protein, whereas membrane-associated proteins like the integral outer 14 
membrane protein ATOM or the inner membrane protein COXIV require more stringent 15 
extraction conditions for their solubilization (Fig 4E). Thus from our current data we conclude 16 
that TAC102 is not an inner mitochondrial membrane protein but rather localizes to the 17 
unilateral filaments between the kDNA and the mitochondrial inner membrane. 18 
 19 
 20 
 21 
 22 
 23 
Materials and Methods 24 
 25 
Cell lines and culture conditions 26 
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Bloodstream form T. brucei cells were cultured in HMI-9 medium with 10% FCS at 37°C and 1 
5% CO2, and procyclic trypanosomes were maintained in SDM-79 medium with 10% FCS at 2 
27°C. For transfections, the New York single marker (NYsm) or the γ-L262P strains of BSF 3 
T. brucei and the 29-13 strain of PCF T. brucei were used. Cells were transfected with NotI-4 
linearized plasmids by electroporation and then selected with appropriate antibiotics, by 5 
limiting dilutions. NYsm BSF and 29-13 PCF trypanosomes were obtained from the 6 
established collection of the Institute of Cell Biology, University of Bern, Bern, Switzerland. 7 
The γ-L262P strain of BSF cells is a kind gift of A. Schnaufer. 8 
DNA constructs 9 
The TAC102 RNAi constructs were targeted against the 451−1021 bp of the ORF of the gene 10 
Tb927.7.2390 or against the 147−646 bp of the 3’-UTR of this gene. Briefly, a PCR fragment 11 
with adaptor sequences was amplified from genomic DNA of NYsm BSF cells, and cloned in 12 
two steps into the pTrypRNAiGate vector by Gateway® cloning. The final plasmids were 13 
used for transfection as described above. RNAi was induced by addition of 1 µg/ml 14 
tetracycline. For N-terminal triple myc-tagging of TAC102, the full-length sequence of the 15 
gene (1−951 bp) or the ∆N sequence (200−951 bp) or the ∆C sequence (1−650 bp) were 16 
amplified by PCR from genomic DNA of NYsm BSF trypanosomes and cloned into the pJM-17 
2 vector (gift of A. Schneider). The final plasmids were used for transfection as described 18 
above. Expression was induced by addition of 1 µg/ml tetracycline. For N-terminal PTP-19 
tagging of TAC102, the ORF positions 4 to 707 were amplified from genomic DNA and 20 
cloned between ApaI/NotI sites of pN-PURO-PTP vector. The resulting plasmid was 21 
linearized with XbaI prior to transfection. This construct was recombined into the endogenous 22 
locus to substitute for one of the TAC102 alleles and thus was constantly expressed. For GFP-23 
301aa, GFP-116aa and GFP-36aa constructs, the respective parts of TAC102 (PCR products) 24 
and GFP (PCR product) were fused together by fusion PCR and ligated between 25 
HindIII/BamHI sites into the pFS-3 expression plasmid (gift of A. Schneider). For the GFP-26 
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18aa construct, GFP was PCR amplified with a reverse primer that contained the sequence of 1 
the last 18 aa of TAC102 and cloned into pFS-3. For the Ntarget-GFP construct, the N-2 
terminal mitochondrial targeting sequence of the Rieske iron-sulfur protein (Tb927.9.14160, 3 
1−72 bp) was ligated between XhoI/AgeI sites into the pG-EGFP-ΔFPt vector [52], then the 4 
obtained Ntarget-GFP sequence was cut out by HindIII/BamHI and cloned into pFS-3. All 5 
GFP constructs were linearized with NotI and transfected into 29-13 PCF cells as described 6 
above. Expression was induced by addition of 1 Fa" : { "ISBN" : "0 7 
 8 
 9 
Recombinant TAC102 and antibodies against it 10 
The recombinant version of TAC102 was expressed in E. coli BL21 strain as a fusion with the 11 
maltose-binding protein (MBP) at the N-terminus of TAC102, using the pMAL® system 12 
(New England Biolabs). The fusion protein was purified on amylose resin and analysed by 13 
mass-spectrometry. The purified product was used to generate polyclonal antibodies in rats 14 
(Eurogentec, Belgium). The monoclonal antibody was produced in mice (GenScript, USA) 15 
against a synthetic peptide that represented the 500−660 aa of TAC102. Specificity of both 16 
antibodies was confirmed by western blotting and immunofluorescence microscopy, in PCF 17 
and BSF cells (Fig S2). 18 
 19 
SDS-PAGE and western blotting 20 
SDS-PAGE was carried out as described elsewhere, in 8%, 10% or 15% SDS-polyacrylamide 21 
gels. The gels were either stained with Coomassie blue R250 or, for western analysis, 22 
transferred onto PVDF membranes. Blocking was performed in 5% or 10% skimmed milk 23 
solution in PBS or PBST (PBS + 0.1% TWEEN-20). Primary antibodies were: mouse 24 
monoclonal α-TAC102 (1:1000, GenScript), rat polyclonal α-TAC102 (1:1000, Eurogentec), 25 
rabbit α-ProteinA (1:5000, Sigma), rabbit α-myc (1:1000, Sigma), mouse α-myc (1:1000, 26 
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Sigma), mouse α-EF1α (1:10000, SantaCruz), rabbit α-ALBA3 (1:1000, [53]), rabbit α-1 
ATOM (1:10000, [54]), mouse α-GFP (1:1000, Sigma), rabbit atGFP (1:1000, Sigma), rabbit 2 
atCOXIV (1:1000), rabbit b-LipDH (1:10000, [55]). Secondary antibodies were: rabbit α 3 
SecoHRP-conjugate (1:10000, Dako), rabbit α-mouse HRP-conjugate (1:10000, Dako), swine 4 
α-rabbit HRP-conjugate (1:10000, Dako), goat α-rat 680 LT (1:10000, LI-COR), goat α-5 
mouse 800 CW (1:10000, LI-COR), goat α-rabbit 680 LT (1:10000, LI-COR). 6 
Digitonin fractionations 7 
Cells were collected by centrifugation at 2500 rcf for 8 min at room temperature, washed once 8 
with PBS, re-suspended in SoTE buffer (0.6 M sorbitol, 2 mM EDTA, 20 mM Tris-HCl, pH 9 
7.5) such that 107 cells were in 25 μc of the buffer, and an equal volume of 0.05% digitonin 10 
solution in SoTE buffer was added. Alternatively, to use other digitonin concentrations (Fig 11 
4E), the PBS-washed cells were directly re-suspended in SoTE containing the necessary 12 
amount of digitonin, to the final volume. The cells were then incubated on ice for 5 min and 13 
then centrifuged at 8000 rcf for 5 min at 4°C. The supernatant (cytosolic fraction) was 14 
separated from the pellet (mitochondria) and both fractions were lysed in Laemmli buffer. 15 
 16 
Northern blotting 17 
Total RNA was extracted from trypanosomes with RiboZol (Amresco) and separated in 1.4% 18 
agarose gels with 6% formaldehyde and transferred onto nylon membranes in 10×SSC. The 19 
probe for TAC102 ORF was generated from a PCR fragment that had been used for creation 20 
of the RNAi construct, by incorporation of α-P32-dCTP using RadPrime DNA Labeling 21 
System (Invitrogen). Blots were re-probed for 18S rRNA to ensure equal loading of samples. 22 
18S rRNA probe was generated by T4 PNK labelling of an oligonucleotide (which is 23 
complementary to 18S rRNA) with γ-P32-ATP. 24 
 25 
Southern blotting 26 
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Total DNA was extracted from trypanosomes with phenol/chloroform as described elsewhere, 1 
and digested overnight at 37°C with HindIII and XbaI. Reaction mixtures were separated in 2 
1% agarose gels in 1×TAE buffer. After this, the gels were washed twice for 10 min in 3 
depurination solution (0.25 M HCl), once for 30 min in denaturation solution (1.5 M NaCl, 4 
0.5 M NaOH), twice for 15 min in neutralization solution (3 M NaCl, 0.5 M Tris-HCl, pH 5 
7.5), twice for 15 min in 20×SSC and then transferred onto nylon membranes in 20×SSC. The 6 
probe for minicircles was generated from a PCR fragment (approx. 100 bp of the conserved 7 
minicircle sequence) amplified from total DNA of NYsm BSF T. brucei, by incorporation of 8 
α-P32-dCTP using RadPrime DNA Labeling System (Invitrogen). Blots were re-probed for the 9 
intergenic region between n between he intergenic region between SF l DNA of NYsm BSF F  10 
total DNA of NYsm BSF SF toPCR fragment amplified from total DNA of NYsm BSF T. 11 
brucei, by incorporation of α-P32-dCTP and α-P32-dATP using RadPrime DNA Labeling 12 
System (Invitrogen). Southern analysis was repeated three times. 13 
 14 
Immunofluorescence 15 
BSF or PCF cells were fixed on slides with 4% PFA in PBS, permeabilized for 5 min with 16 
0.2% TritonX-100 in PBS and blocked for 30 min with 4% BSA in PBS. Primary and 17 
secondary antibodies were diluted in 4% BSA in PBS. Primary antibodies were: mouse 18 
monoclonal α-TAC102 (1:1000), rat polyclonal α-TAC102 (1:1000), rabbit α-ProteinA 19 
(1:1000, Sigma), rat α-YL1/2 (1:2000), mouse α-Mab22 (1:10), rat α-PFR (1:1000, [56]), 20 
mouse α-BBA4 (1:100), rabbit α-myc (1:1000, Sigma), mouse α-myc (1:1000, Sigma), 21 
mouse α-GFP (1:100, Sigma), rabbit seGFP (1:1000, Sigma), mouse se  onItems" : [ , [57]). 22 
The following secondary antibodies (1:1000, Invitrogen) were used: goat α-rabbit IgG, goat 23 
α-rat IgG, goat α-mouse IgG conjugated with fluorophores Alexa Fluor® 488, Alexa 24 
Fluor® 594, Alexa Fluor® 647. Cells were mounted with VECTASHIELD® Mounting 25 
Media with DAPI (Vector Laboratories) or ProLong® Gold Antifade Mountant with DAPI 26 
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(Invitrogen). Images were acquired with the Leica DM 5500 fluorescent light microscope and 1 
deconvolved by the Leica LAS AF software. For evaluation of kDNA intensities, ImageJ 2 
software was used. 3 
 4 
Flagellar extraction 5 
Trypanosomes in medium with 5 mM EDTA were centrifuged and re-suspended in extraction 6 
buffer (10 mM NaH2PO4, 150 mM NaCl, 1 mM MgCl2) containing 0.5% TritonX-100, on ice. 7 
After one washing step with extraction buffer, cells were incubated on ice for 45 min in 8 
extraction buffer containing 1 mM CaCl2 and then subjected to immunofluorescence analysis 9 
(IFA). 10 
 11 
STED 12 
For super-resolution microscopy cells were stained with 200 nm MitoTracker® Red CMXRos 13 
(Thermo Fisher) for 20 min at 37°C. The following staining procedure was performed as 14 
described above. The primary antibody was rabbit α-ProteinA (1:1000, Sigma) and the 15 
secondary antibody was goat t e was pIgG Oregon Green® 488 (1:100, Invitrogen). Cells 16 
were mounted with ProLong® Gold Antifade mounting solution (Invitrogen). The images 17 
were acquired with Leica SP8 Confocal Microscope System with STED and deconvolved 18 
with Huygens professional software. 19 
 20 
Electron microscopy 21 
Trypanosomes were grown as described above, harvested and centrifuged at 3345 rcf for 5 22 
min and the pellets were submerged with fixative which was prepared as follows: 2.5% 23 
glutaraldehyde (Agar Scientific, Stansted, Essex, UK) in 0.15 M HEPES (Fluka, Buchs, 24 
Switzerland) with osmolarity of 684 mOsm and adjusted to pH 7.41. The cells remained in 25 
the fixative at 4°C for at least 24 hours before further processing. They were then washed 26 
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with 0.15 M HEPES two times for 5 min, post-fixed with 1% OsO4 (SPI Supplies, West 1 
Chester, USA) in 0.1 M Na-cacodylate buffer (Merck, Darmstadt, Germany) at 4°C for 1 h, 2 
washed with 0.05 M maleate-NaOH buffer (Merck, Darmstadt, Germany) three times for 5 3 
min, and then block-stained in 0.5% uranyl acetate (Fluka, Buchs, Switzerland) in 0.05 M 4 
maleate-NaOH buffer at 4°C for 1 h. Then the cells were washed in 0.05 M maleate-NaOH 5 
buffer three times for 5 min and dehydrated in 70, 80, and 96% ethanol (Alcosuisse, 6 
Switzerland) for 15 min each at room temperature. Subsequently, the cells were immersed in 7 
100% ethanol (Merck, Darmstadt, Germany) three times for 10 min, in acetone (Merck, 8 
Darmstadt, Germany) two times for 10 min, and finally in acetone-Epon (1:1) overnight at 9 
room temperature. The next day, cells were embedded in Epon (Fluka, Buchs, Switzerland) 10 
and left to harden at 60°C for five days. Sections were produced with an ultramicrotome UC6 11 
(Leica Microsystems, Vienna, Austria), first – semi-thin sections (1 µm) for light microscopy, 12 
which were stained with solution of 0.5% toluidine blue O (Merck, Darmstadt, Germany), and 13 
then – ultrathin sections (70−80 nm) for electron microscopy. The sections, mounted on 200 14 
mesh copper grids, were stained with uranyl acetate and lead citrate with an ultrostainer 15 
(Leica Microsystems, Vienna, Austria). Sections were then examined with a transmission 16 
electron microscope (CM12, Philips, Eindhoven) equipped with a digital camera (Morada, 17 
Soft Imaging System, Münster, Germany). 18 
 19 
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Supporting Information Captions 8 
 9 
Fig S1. Conservation and posttranslational modification of TAC102. A – a stick figure 10 
displaying conserved regions (violet) of the TAC102 protein sequence as well as 11 
phosphorylation sites at positions 609 and 614. The non-conserved regions are depicted in 12 
pink. B – a phylogenetic tree showing conservation of TAC102 among Kinetoplastea. The 13 
tree was reconstructed using PhyML based on a manually curated sequence alignment using 14 
MUSCLE. C – a table showing conservation of the two identified phosphorylation sites 15 
(609T and 614S) in TAC102 orthologs in several Kinetoplastea. D – mRNA expression levels 16 
during the G1, S and G2/M phases of the cell cycle of PCF trypanosomes. Shown are the 17 
relative expression levels normalized to the highest expression of each of the transcripts 18 
(100%). The data is based on cells sorted by DNA content followed by mRNA extraction and 19 
spliced leader based Illumina sequencing as described previously [58]. Shown are the 20 
examples of the currently known TAC components. 21 
 22 
Fig S2. TAC102 RNAi in PCF cells and antibodies against TAC102. A-C: RNAi against 23 
the ORF of TAC102 in PCF cells. A – a growth curve showing the onset of a growth defect 24 
after day 4 of RNAi induction. Inset: a northern blot confirming downregulation of TAC102 25 
mRNA after two days of RNAi induction. 18S rRNA is used as a loading control. B – 26 
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epifluorescence images (DAPI staining) showing missegregation and loss of kDNA after two 1 
days of RNAi induction. Compare a cell with a “normal” kDNA (*), with a large kDNA (**) 2 
and without kDNA (***). C – percentage of cells with different k-n-combinations within the 3 
course of TAC102 RNAi. The number of 1k1n cells (triangles) decreases significantly and 4 
0k1n cells (crosses) become the dominant cell type. D-I: RNAi against the 3’-UTR of 5 
TAC102 in PCF cells. D – a growth curve showing the onset of a growth defect after day 4 6 
of RNAi induction. E – a western blot showing a decrease in the amount of TAC102 protein 7 
upon its depletion by RNAi. EF1α is used as a loading control. F – percentage of cells with 8 
different k-n-combinations within the course of TAC102 RNAi. The number of 1k1n cells 9 
(blue circles) decreases significantly and 0k1n cells (red triangles) become the dominant cell 10 
type. G – epifluorescence images (DAPI staining) showing loss of kDNA after three and five 11 
days of RNAi induction. H – epifluorescence images showing an example of cells with 12 
missegregated kDNA on day 4 of RNAi induction, one with a small kDNA and another with a 13 
big one. I – fluorescence images showing examples of induced cells (3 days of RNAi) that 14 
have lost or missegregated the kDNA. DNA is stained with DAPI (cyan) and flagella are 15 
stained with α-PFR antibody (gray). J-N: recombinant TAC102 and antibodies against 16 
TAC102. J – a Coomassie stained SDS-PAAG showing expression of the recombinant 17 
version of TAC102 with MBP at its N-terminus in E. coli. After purification on amylose two 18 
major forms of the recombinant protein are detected, the bigger one (full-length) and the 19 
smaller one (C-terminally processed by bacteria). K – western blots showing that rat 20 
polyclonal antibodies recognize TAC102 in PCF and BSF. The mouse monoclonal antibody 21 
recognizes TAC102 as well. L – a western blot showing that TAC102 is present in BSF and 22 
PCF trypanosomes in similar amounts. EF1α is used as a loading control. M – an 23 
immunofluorescence image showing a BSF cell expressing N-PTP-TAC102. DNA is stained 24 
with DAPI (cyan). The signal of N-PTP-TAC102 (visualized by α-ProteinA antibody, red) 25 
and the signal of the rat α-TAC102 antibody (green) co-localize. Scale bar 1 ody N – an 26 
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immunofluorescence image showing a PCF cell expressing N-3×myc-TAC102. DNA is 1 
stained with DAPI (cyan). The signals of N-3×myc-TAC102 (visualized by α-myc antibody, 2 
red), mouse monoclonal α-TAC102 antibody (blue) and rat polyclonal α-TAC102 antibody 3 
(green) co-localize. 4 
 5 
Fig S3. Flagella isolated from PCF cells retain TAC102. Flagella were extracted from PCF 6 
trypanosomes with 0.5% TritonX-100, as described in Materials and Methods, and treated 7 
with DNAse I or left untreated. A – immunofluorescence images showing: an untreated 8 
flagellum (upper panel) that retains the kDNA (stained with DAPI, cyan) and TAC102 9 
(magenta); a DNAse I–treated flagellum (lower panel) that has lost the kDNA but retains 10 
TAC102. B – a western blot showing that TAC102 is present in both the flagellar extract and 11 
the supernatant. The same is observed for αetubulin. EF1α, a cytosolic protein, is found 12 
only in the soluble fraction. Since flagella that were not treated with DNAse I were difficult to 13 
handle we could not detect any of these proteins in that fraction. For each flagellar fraction, 14 
the loaded cell equivalent was twice more than that of the supernatant. 15 
 16 
Fig S4. RNAi against TAC102 in BSF cells induced for 18 hours. At this early time point, 17 
some cells lose the TAC102 signal as well as the kDNA, but it happens preferably at the more 18 
posterior basal body (examples in the middle panel and the lower panel, compare to non-19 
induced cells in the upper panel). YL1/2 is used as a basal body marker (green), TAC102 is 20 
shown in red, DAPI staining of DNA – in cyan. 21 
 22 
Fig S5. Ectopic expression of the myc:full, myc:ΔN and myc:ΔC versions of TAC102 in 23 
PCF cells followed for five days upon induction. DNA is stained with DAPI (cyan) and 24 
myc-tagged proteins (visualized by α-myc antibody) are shown in magenta. Expression of 25 
the myc:full protein (upper set of panels) does not affect the kDNA and the protein localizes 26 
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to the position of the endogenous TAC102. Expression of the myc:ΔN protein (middle set of 1 
panels) causes appearance of ancillary kinetoplasts (day 5, indicated with a star); the protein 2 
accumulates in multiple locations (day 5, indicated with arrows) and is present at the site of 3 
the ancillary kinetoplast. Expression of the myc:ΔC protein (lower set of panels) does not 4 
affect the kDNA and the protein localizes to the cytoplasm. 5 
 6 
Fig S6. Quantification of k-n-numbers and ancillary kinetoplasts in selected cell lines. A 7 
– a column chart showing percentages of cells with different k-n-numbers in the following 8 
PCF cell lines: myc:full, overexpression for five days (red); myc:yc:s (red); myc:for  fofive 9 
days (green); RNAi against the 3´-UTR of TAC102, non-induced cells (blue); RNAi against 10 
the 3´-UTR of TAC102, induced for five days (yellow); myc:full in the background of RNAi 11 
against the 3´-UTR of TAC102, induced for five days (gray); myc:yc:yc:t the 3´-UTR of 12 
TARNAi against the 3heUTR of TAC102, induced for five days (violet). B – a column chart 13 
showing percentages of cells with different numbers of ancillary kinetoplasts per cell. The 14 
percentages displayed are of the cells with ancillary kinetoplasts, and not of all cells in the 15 
population. The data is shown for three PCF cell lines where “extra” kDNAs were observed: 16 
myc:yc, overexpression for five days; myc:full in the background of RNAi against the 3´-17 
UTR of TAC102, induced for five days; myc:yc:s; myc:e 3´-UTR of TARNAi against the 18 
3heUTR of TAC102, induced for five days. 19 
 20 
Fig S7. Amphipathic helices at the C-terminus of TAC102. The schematic α-helices show 21 
the last 18 aa (A) or 36 aa (B) of the C-terminal sequence of TAC102. The schemes were 22 
constructed by the online tool available at http://rzlab.ucr.edu/scripts/wheel/wheel.cgi. 23 
Hydrophilic residues are shown as circles, hydrophobic residues – as diamonds, potentially 24 
negatively charged – as triangles, and potentially positively charged – as pentagons. 25 
Hydrophobicity has a color code: the most hydrophobic residues are green, and the amount of 26 
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green decreases proportionally to the hydrophobicity, with zero hydrophobicity shown in 1 
yellow. Hydrophilic residues are red, with pure red being the most hydrophilic (uncharged) 2 
residue, and the amount of red decreasing proportionally to the hydrophilicity. The potentially 3 
charged residues are light blue. Based on the distribution of amino acid residues in these α 4 
helices, both the last 18 aa (A) and the last 36 aa (B) of the C-terminal sequence of TAC102 5 
form amphipathic helices. 6 
The last 18 aa of TAC102: 7 
DSIKKSSKVSLILRQLIK (numbers 1–18 in scheme A) 8 
The last 36 aa of TAC102: 9 
VNGIDLHNATKSIRLQAMDSIKKSSKVSLILRQLIK (numbers 1–36 in scheme B) 10 
 11 
Fig S8. Ectopic expression of GFP chimeras C-terminally fused with C-terminal parts of 12 
TAC102 in PCF cells. Expression was induced overnight. Immunofluorescence images show 13 
the localization of the GFP chimeras (visualized by α-GFP antibody, green). ATOM is a 14 
mitochondrial marker protein, visualized by α-ATOM antibody (red). DNA is stained with 15 
DAPI (cyan). On the right side of the immunofluorescence images, western blots of digitonin 16 
fractionations for each cell line are shown. ATOM and EF1α (a cytosolic protein) are used as 17 
fractionation controls. T, total cell lysate; S, supernatant; P, pellet. Ntarget-GFP: a control 18 
PCF cell line expressing GFP with an N-terminal mitochondrial targeting sequence of the 19 
Rieske iron-sulfur protein (Tb927.9.14160, 1−72 bp). This chimera co-localizes with ATOM 20 
and mitochondrial morphology is intact. GFP-301aa, GFP-116aa, GFP-36aa, GFP-18aa: 21 
PCF cell lines expressing GFP with the respective number of C-terminal amino acids of 22 
TAC102 fused to its C-terminus. GFP-301aa appears to co-localize with ATOM, but 23 
mitochondrial morphology is compromised (compare the localization of ATOM with the one 24 
seen in the Ntarget-GFP cell). GFP-116aa, GFP-36aa, GFP-18aa chimeras localize to the 25 
cytoplasm, but mitochondrial morphology as seen by staining for ATOM remains intact. 26 
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 1 
Fig S9. PCF cells expressing GFP-301aa after 1 hour of induction. The GFP chimera is 2 
visualized by α-GFP antibody (green). The mitochondrial heat-shock protein 70 (mtHSP70) 3 
is used as a mitochondrial marker (red). DNA is stained with DAPI (cyan). At this early time 4 
point of induction, few cells express GFP-301aa, which makes its detection by western 5 
blotting rather challenging. However, mitochondrial morphology as seen by mtHSP70 6 
staining is unaffected, and GFP-301aa appears to co-localize with mtHSP70 in the cells that 7 
express GFP-301aa. 8 









